ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...
A5361s is a prospective study to determine the effects of pitavastatin on physical function. The study will enroll participants...
Using existing data from A5274 and data obtained from retrospectively testing available biospecimens, we propose the following...
An estimated 3 million HIV-infected individuals will enter programs for antiretroviral (ARV) treatment in the coming year, with...
TB is a major cause of illness and death in women of reproductive age. Pregnant and postpartum women with latent TB are at...
